In this interview with Arjan Diepstra, PhD, from the University of Groningen, Groningen, Netherlands, speaking from the 23rd congress of the European Haematology Association (EHA) 2018, held in Stockholm, Sweden, gives a brief overview of the role of biomarkers in lymphoma. Dr Diepstra covers how they can be used to determine patient prognosis and influence clinical decisions. He highlights the TARC biomarker currently being used in Hodgkin lymphoma.
Biomarkers in lymphoma
